According to the company, AurPROFILER enables researchers to rapidly evaluate target, cell and drug profiles using bio-assays derived from the activity data found in Aureus Pharma’s AurSCOPE target knowledge databases.
AurPROFILER is said to have been designed to work in conjunction with the AurSCOPE Global Pharmacology Space and Aureus’s entire drug target focused knowledge databases.
AurPROFILER was developed in collaboration with a pharmaceutical industry focus group consisting of several major pharmaceutical companies.
Jason Theodosiou, president and CEO of Aureus Pharma, said: “AurPROFILER is an example where the combination of Aureus’s analysis capabilities and the high quality data within AurSCOPE Knowledge databases combine to bring additional value to researchers.”